29May/13

La Jolla Pharmaceutical Company Reports Results From GCS-100 Phase 1 … – MarketWatch (press release)

La Jolla Pharmaceutical Company Reports Results From GCS-100 Phase 1
MarketWatch (press release)
Chronic kidney disease (“CKD”) currently affects 14% of Americans or approximately 49 million people. The United States Renal Data System, 2012 Annual Data Report, states that in 2010, costs for CKD reached $41 billion for Medicare alone. GCS-100

and more »